IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BECCIOLINI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 520
EU - Europa 509
AS - Asia 370
SA - Sud America 84
AF - Africa 10
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 1.500
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 497
IT - Italia 191
CN - Cina 127
SG - Singapore 114
BR - Brasile 72
GB - Regno Unito 72
SE - Svezia 72
DE - Germania 37
RU - Federazione Russa 36
IE - Irlanda 25
FR - Francia 23
ID - Indonesia 22
IN - India 22
CA - Canada 17
HK - Hong Kong 16
JP - Giappone 14
TW - Taiwan 12
FI - Finlandia 10
NL - Olanda 9
TR - Turchia 8
BE - Belgio 6
KR - Corea 6
ES - Italia 5
CO - Colombia 4
GR - Grecia 4
MX - Messico 4
ZA - Sudafrica 4
AP - ???statistics.table.value.countryCode.AP??? 3
AR - Argentina 3
AU - Australia 3
CZ - Repubblica Ceca 3
PK - Pakistan 3
PT - Portogallo 3
UA - Ucraina 3
AT - Austria 2
BD - Bangladesh 2
BG - Bulgaria 2
CY - Cipro 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EC - Ecuador 2
IL - Israele 2
IR - Iran 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
MY - Malesia 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
ET - Etiopia 1
GE - Georgia 1
HU - Ungheria 1
IQ - Iraq 1
JO - Giordania 1
KG - Kirghizistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 1.500
Salva come PNG Salva come JPEG
Città #
Chandler 85
Singapore 79
Santa Clara 58
Milan 47
Southend 47
Council Bluffs 30
Princeton 28
Ashburn 25
Dublin 24
Rome 19
Fairfield 18
Jakarta 18
Cambridge 12
Hong Kong 12
New York 12
Beijing 11
Bengaluru 11
Guangzhou 11
Woodbridge 11
Bologna 10
Seattle 10
Ann Arbor 9
Medford 9
Tokyo 9
Toronto 9
Helsinki 8
Houston 8
Wilmington 8
Grafing 7
Dearborn 6
Florence 6
Jinan 6
Munich 6
San Diego 6
Shanghai 6
Des Moines 5
Los Angeles 5
Annecy 4
Frankfurt am Main 4
Naples 4
New Delhi 4
Nuremberg 4
Phoenix 4
Rio de Janeiro 4
São Paulo 4
Trieste 4
Turin 4
Verona 4
Ankara 3
Athens 3
Boardman 3
Brasília 3
Haikou 3
Hebei 3
Nanjing 3
Palermo 3
Portici 3
Quanzhou 3
Rho 3
Aberdeen 2
Amsterdam 2
Blida 2
Bogotá 2
Bratislava 2
Brno 2
Brussels 2
Burlington 2
Cape Town 2
Casablanca 2
Castel Goffredo 2
Central District 2
Changsha 2
Corroios 2
Curitiba 2
Delhi 2
Duncan 2
Edinburgh 2
Fremont 2
Fucecchio 2
Fuzhou 2
Gujranwala 2
Hangzhou 2
Isola Vicentina 2
Istanbul 2
Kalken 2
Kuala Lumpur 2
London 2
Lucera 2
Madrid 2
Melbourne 2
Melito di Napoli 2
Melzo 2
Monopoli 2
Nicosia 2
Nova Friburgo 2
Québec 2
Redwood City 2
Ridderkerk 2
San Francisco 2
Sesto San Giovanni 2
Totale 850
Salva come PNG Salva come JPEG
Nome #
Eight-year retention rate of first-line tumor necrosis factor inhibitors in spondyloarthritis : A multi-center retrospective analysis 339
Reliability and validity of the Italian version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in patients with systemic sclerosis 198
The management of first-line biologic therapy failures in rheumatoid arthritis : current practice and future perspectives 87
The Expanded Risk Score in Rheumatoid Arthritis (ERS-RA): performance of a disease-specific calculator in comparison with the traditional prediction scores in the assessment of the 10-year risk of cardiovascular disease in patients with rheumatoid arthrit 84
The profiling of axial spondyloarthritis patient candidate to a biologic therapy : consensus from a Delphi-panel of Italian experts 66
The role of concomitant methotrexate dosage and maintenance over time in the therapy of rheumatoid arthritis patients treated with adalimumab or etanercept : Retrospective analysis of a local registry 64
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 61
Two-year persistence of golimumab as second-line biologic agent in rheumatoid arthritis as compared to other subcutaneous tumor necrosis factor inhibitors : real-life data from the LORHEN registry 59
Sex and Management of Rheumatoid Arthritis 57
Sarilumab : patient-reported outcomes in rheumatoid arthritis 55
The 12-item psoriatic arthritis impact of disease questionnaire : Construct validity, reliability, and interpretability in a clinical setting 55
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis : Evidence to date 55
Tocilizumab in the treatment of rheumatoid arthritis : An evidence-based review and patient selection 54
Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations : similarities and differences 53
The role of methotrexate as combination therapy with etanercept in rheumatoid arthritis: Retrospective analysis of a local registry 48
Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects 47
A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: Focus on interchangeability 44
Is there a need for new thresholds to define remission and low disease activity by disease activity score 28 calculated with C reactive protein? real life data from a local registry 41
Change over time in the pattern of clinical response to first-line biologic drugs in patients with rheumatoid arthritis: Observational data in a real-life setting 35
Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritis 27
Structural integrity versus radiographic progression in rheumatoid arthritis 23
Vitamin D and spondyloarthritis: Review of the literature 22
Profile of sarilumab and its potential in the treatment of rheumatoid arthritis 4
Totale 1.578
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.287
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.287
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 0 0 0 0 9 9 4 3
2020/202164 8 3 4 3 4 4 5 5 15 6 2 5
2021/2022159 2 4 2 1 3 1 1 54 17 7 19 48
2022/2023322 46 28 24 19 44 52 5 23 40 3 28 10
2023/2024198 9 20 7 9 49 13 11 7 7 11 18 37
2024/2025575 17 52 57 92 108 61 71 81 36 0 0 0
Totale 1.578